Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Imunon, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q3 2024
- Shares held
- 425.1K
- −590.6K (−58.1%) vs. Q3 2024
- Total value
- $403.5K
- −$673.0K (−62.5%) vs. Q3 2024
- New holders
- 7
- 3 more added
- Sold out
- 6
- 5 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMNN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $506.1K |
| Q1 2026 | 19 | $1.63M |
| Q4 2025 | 20 | $1.76M |
| Q3 2025 | 17 | $879.0K |
| Q2 2025 | 26 | $1.76M |
| Q1 2025 | 19 | $359.9K |
| Q4 2024 | 22 | $403.5K |
| Q3 2024 | 22 | $1.08M |
| Q2 2024 | 18 | $442.0K |
| Q1 2024 | 18 | $539.4K |
| Q4 2023 | 22 | $285.9K |
| Q3 2023 | 18 | $402.9K |
| Q2 2023 | 17 | $515.1K |
| Q1 2023 | 19 | $513.3K |
| Q4 2022 | 22 | $572.7K |
| Q3 2022 | 22 | $818.1K |
| Q2 2022 | 25 | $1.69M |
| Q1 2022 | 24 | $2.66M |
| Q4 2021 | 42 | $4.14M |
| Q3 2021 | 40 | $8.54M |
| Q2 2021 | 43 | $11.5M |
| Q1 2021 | 47 | $16.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Imunon, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 139,505 | $132.6K | 0.00% | +13,570+10.8% | Added |
| BlackRock, Inc. | 58,222 | $55.3K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 48,806 | $46.4K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 40,097 | $38.0K | 0.00% | +40,095+2,004,750.0% | Added |
| Renaissance Technologies LLC | 33,561 | $31.9K | 0.00% | −30,050−47.2% | Reduced |
| Northern Trust Corp | 21,640 | $20.6K | 0.00% | +21,640 | New |
| XTX Topco Ltd | 21,413 | $20.3K | 0.00% | +21,413 | New |
| State Street Corp | 21,303 | $20.2K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 19,214 | $18.0K | 0.00% | +19,214 | New |
| Citadel Advisors LLC | 12,825 | $12.2K | 0.00% | −21,160−62.3% | Reduced |
| Tower Research Capital LLC (TRC) | 4,864 | $4.62K | 0.00% | −25−0.5% | Reduced |
| Morgan Stanley | 1,631 | $1.55K | 0.00% | −500−23.5% | Reduced |
| Citigroup Inc | 1,299 | $1.23K | 0.00% | +1,299 | New |
| Fourth Dimension Wealth, LLC | 250 | $238 | 0.00% | +250 | New |
| Group One Trading, L.P. | 129 | $123 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 117 | $111 | 0.00% | −1−0.8% | Reduced |
| JPMorgan Chase & Co | 100 | $95 | 0.00% | +100 | New |
| Federation des caisses Desjardins du Quebec | 66 | $63 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 22 | $21 | 0.00% | +1+4.8% | Added |
| SBI Securities Co., Ltd. | 4 | $4 | 0.00% | +4 | New |
| Game Plan Financial Advisors, LLC | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2 | $1 | 0.00% | 00.0% | Unchanged |
| Sabby Management, LLC | 0 | $0 | 0.00% | −608,203−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,169−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,503−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,521−100.0% | Sold out |
| Nations Financial Group Inc, | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| M&R Capital Management Inc | – | – | – | – | Not filed |